Global Anti - Neoplastic Agents Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 152705
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 137
  • list Pharmaceuticals and Healthcare

Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.

Scope of the Report:

The worldwide market for Anti - Neoplastic Agents is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Anti - Neoplastic Agents in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Roche

Novartis

Celgene

Bristol-Myers Squibb

Amgen

Johnson & Johnson

Pfizer

Takeda

Eli Lilly

AstraZeneca

Astellas

Merck & Co.

Sanofi

Bayer

Biogen Idec

Eisai

Teva

Otsuka

Merck KGaA

Ipsen

AbbVie

Gilead Sciences

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Chemotherapy

Targeted Therapy

Immunotherapy

Hormonal Therapy (Biologic Therapy)

Others

Market Segment by Applications, can be divided into

Blood Cancer

Breast Cancer

Gastrointestinal Cancer

Prostate Cancer

Respiratory/Lung Cancer

Other Cancers

There are 15 Chapters to deeply display the global Anti - Neoplastic Agents market.

Chapter 1, to describe Anti - Neoplastic Agents Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Anti - Neoplastic Agents, with sales, revenue, and price of Anti - Neoplastic Agents, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Anti - Neoplastic Agents, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Anti - Neoplastic Agents market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Anti - Neoplastic Agents sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Anti - Neoplastic Agents Introduction

1.2 Market Analysis by Type

1.2.1 Chemotherapy

1.2.2 Targeted Therapy

1.2.3 Immunotherapy

1.2.4 Hormonal Therapy (Biologic Therapy)

1.2.5 Others

1.3 Market Analysis by Applications

1.3.1 Blood Cancer

1.3.2 Breast Cancer

1.3.3 Gastrointestinal Cancer

1.3.4 Prostate Cancer

1.3.5 Respiratory/Lung Cancer

1.3.6 Other Cancers

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Roche

2.1.1 Business Overview

2.1.2 Anti - Neoplastic Agents Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Roche Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Novartis

2.2.1 Business Overview

2.2.2 Anti - Neoplastic Agents Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Novartis Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Celgene

2.3.1 Business Overview

2.3.2 Anti - Neoplastic Agents Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Celgene Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Bristol-Myers Squibb

2.4.1 Business Overview

2.4.2 Anti - Neoplastic Agents Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Bristol-Myers Squibb Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Amgen

2.5.1 Business Overview

2.5.2 Anti - Neoplastic Agents Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Amgen Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Johnson & Johnson

2.6.1 Business Overview

2.6.2 Anti - Neoplastic Agents Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Johnson & Johnson Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Pfizer

2.7.1 Business Overview

2.7.2 Anti - Neoplastic Agents Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Pfizer Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Takeda

2.8.1 Business Overview

2.8.2 Anti - Neoplastic Agents Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Takeda Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Eli Lilly

2.9.1 Business Overview

2.9.2 Anti - Neoplastic Agents Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Eli Lilly Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 AstraZeneca

2.10.1 Business Overview

2.10.2 Anti - Neoplastic Agents Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 AstraZeneca Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Astellas

2.11.1 Business Overview

2.11.2 Anti - Neoplastic Agents Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Astellas Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Merck & Co.

2.12.1 Business Overview

2.12.2 Anti - Neoplastic Agents Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Merck & Co. Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.13 Sanofi

2.13.1 Business Overview

2.13.2 Anti - Neoplastic Agents Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Sanofi Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.14 Bayer

2.14.1 Business Overview

2.14.2 Anti - Neoplastic Agents Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Bayer Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.15 Biogen Idec

2.15.1 Business Overview

2.15.2 Anti - Neoplastic Agents Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 Biogen Idec Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.16 Eisai

2.16.1 Business Overview

2.16.2 Anti - Neoplastic Agents Type and Applications

2.16.2.1 Product A

2.16.2.2 Product B

2.16.3 Eisai Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.17 Teva

2.17.1 Business Overview

2.17.2 Anti - Neoplastic Agents Type and Applications

2.17.2.1 Product A

2.17.2.2 Product B

2.17.3 Teva Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.18 Otsuka

2.18.1 Business Overview

2.18.2 Anti - Neoplastic Agents Type and Applications

2.18.2.1 Product A

2.18.2.2 Product B

2.18.3 Otsuka Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.19 Merck KGaA

2.19.1 Business Overview

2.19.2 Anti - Neoplastic Agents Type and Applications

2.19.2.1 Product A

2.19.2.2 Product B

2.19.3 Merck KGaA Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.20 Ipsen

2.20.1 Business Overview

2.20.2 Anti - Neoplastic Agents Type and Applications

2.20.2.1 Product A

2.20.2.2 Product B

2.20.3 Ipsen Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.21 AbbVie

2.21.1 Business Overview

2.2.2 Anti - Neoplastic Agents Type and Applications

2.21.2.1 Product A

2.21.2.2 Product B

2.21.3 AbbVie Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.22 Gilead Sciences

2.22.1 Business Overview

2.22.2 Anti - Neoplastic Agents Type and Applications

2.22.2.1 Product A

2.22.2.2 Product B

2.22.3 Gilead Sciences Anti - Neoplastic Agents Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Anti - Neoplastic Agents Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Anti - Neoplastic Agents Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Anti - Neoplastic Agents Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Anti - Neoplastic Agents Manufacturer Market Share in 2017

3.3.2 Top 6 Anti - Neoplastic Agents Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Anti - Neoplastic Agents Market Analysis by Regions

4.1 Global Anti - Neoplastic Agents Sales, Revenue and Market Share by Regions

4.1.1 Global Anti - Neoplastic Agents Sales and Market Share by Regions (2013-2018)

4.1.2 Global Anti - Neoplastic Agents Revenue and Market Share by Regions (2013-2018)

4.2 North America Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

4.3 Europe Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

4.5 South America Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

5 North America Anti - Neoplastic Agents by Countries

5.1 North America Anti - Neoplastic Agents Sales, Revenue and Market Share by Countries

5.1.1 North America Anti - Neoplastic Agents Sales and Market Share by Countries (2013-2018)

5.1.2 North America Anti - Neoplastic Agents Revenue and Market Share by Countries (2013-2018)

5.2 United States Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

5.3 Canada Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

5.4 Mexico Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

6 Europe Anti - Neoplastic Agents by Countries

6.1 Europe Anti - Neoplastic Agents Sales, Revenue and Market Share by Countries

6.1.1 Europe Anti - Neoplastic Agents Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Anti - Neoplastic Agents Revenue and Market Share by Countries (2013-2018)

6.2 Germany Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

6.3 UK Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

6.4 France Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

6.5 Russia Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

6.6 Italy Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

7 Asia-Pacific Anti - Neoplastic Agents by Countries

7.1 Asia-Pacific Anti - Neoplastic Agents Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Anti - Neoplastic Agents Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Anti - Neoplastic Agents Revenue and Market Share by Countries (2013-2018)

7.2 China Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

7.3 Japan Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

7.4 Korea Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

7.5 India Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

8 South America Anti - Neoplastic Agents by Countries

8.1 South America Anti - Neoplastic Agents Sales, Revenue and Market Share by Countries

8.1.1 South America Anti - Neoplastic Agents Sales and Market Share by Countries (2013-2018)

8.1.2 South America Anti - Neoplastic Agents Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

8.3 Argentina Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

8.4 Colombia Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

9 Middle East and Africa Anti - Neoplastic Agents by Countries

9.1 Middle East and Africa Anti - Neoplastic Agents Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Anti - Neoplastic Agents Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Anti - Neoplastic Agents Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

9.3 UAE Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

9.4 Egypt Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

9.5 Nigeria Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

9.6 South Africa Anti - Neoplastic Agents Sales and Growth Rate (2013-2018)

10 Global Anti - Neoplastic Agents Market Segment by Type

10.1 Global Anti - Neoplastic Agents Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Anti - Neoplastic Agents Sales and Market Share by Type (2013-2018)

10.1.2 Global Anti - Neoplastic Agents Revenue and Market Share by Type (2013-2018)

10.2 Chemotherapy Sales Growth and Price

10.2.1 Global Chemotherapy Sales Growth (2013-2018)

10.2.2 Global Chemotherapy Price (2013-2018)

10.3 Targeted Therapy Sales Growth and Price

10.3.1 Global Targeted Therapy Sales Growth (2013-2018)

10.3.2 Global Targeted Therapy Price (2013-2018)

10.4 Immunotherapy Sales Growth and Price

10.4.1 Global Immunotherapy Sales Growth (2013-2018)

10.4.2 Global Immunotherapy Price (2013-2018)

10.5 Hormonal Therapy (Biologic Therapy) Sales Growth and Price

10.5.1 Global Hormonal Therapy (Biologic Therapy) Sales Growth (2013-2018)

10.5.2 Global Hormonal Therapy (Biologic Therapy) Price (2013-2018)

10.6 Others Sales Growth and Price

10.6.1 Global Others Sales Growth (2013-2018)

10.6.2 Global Others Price (2013-2018)

11 Global Anti - Neoplastic Agents Market Segment by Application

11.1 Global Anti - Neoplastic Agents Sales Market Share by Application (2013-2018)

11.2 Blood Cancer Sales Growth (2013-2018)

11.3 Breast Cancer Sales Growth (2013-2018)

11.4 Gastrointestinal Cancer Sales Growth (2013-2018)

11.5 Prostate Cancer Sales Growth (2013-2018)

11.6 Respiratory/Lung Cancer Sales Growth (2013-2018)

11.7 Other Cancers Sales Growth (2013-2018)

12 Anti - Neoplastic Agents Market Forecast (2018-2023)

12.1 Global Anti - Neoplastic Agents Sales, Revenue and Growth Rate (2018-2023)

12.2 Anti - Neoplastic Agents Market Forecast by Regions (2018-2023)

12.2.1 North America Anti - Neoplastic Agents Market Forecast (2018-2023)

12.2.2 Europe Anti - Neoplastic Agents Market Forecast (2018-2023)

12.2.3 Asia-Pacific Anti - Neoplastic Agents Market Forecast (2018-2023)

12.2.4 South America Anti - Neoplastic Agents Market Forecast (2018-2023)

12.2.5 Middle East and Africa Anti - Neoplastic Agents Market Forecast (2018-2023)

12.3 Anti - Neoplastic Agents Market Forecast by Type (2018-2023)

12.3.1 Global Anti - Neoplastic Agents Sales Forecast by Type (2018-2023)

12.3.2 Global Anti - Neoplastic Agents Market Share Forecast by Type (2018-2023)

12.4 Anti - Neoplastic Agents Market Forecast by Application (2018-2023)

12.4.1 Global Anti - Neoplastic Agents Sales Forecast by Application (2018-2023)

12.4.2 Global Anti - Neoplastic Agents Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Anti - Neoplastic Agents Picture

Table Product Specifications of Anti - Neoplastic Agents

Figure Global Sales Market Share of Anti - Neoplastic Agents by Types in 20

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery